Related Experiment Video
Updated: Jul 18, 2026
08:58
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Heparin therapy for ulcerative colitis? Effects and mechanisms
N P Michell1, P Lalor, M J Langman
1Department of Medicine, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK.
Summary
Heparin shows promise in treating ulcerative colitis, offering potential anti-inflammatory and healing benefits beyond its anticoagulant properties. This review explores its clinical use and mechanisms for managing this inflammatory bowel disease.
Area of Science:
- Gastroenterology
- Pharmacology
- Immunology
Background:
- Acute colitis, including ulcerative colitis, has high colectomy rates despite standard treatments.
- Heparin's potential therapeutic role in ulcerative colitis emerged from observations in steroid-resistant cases.
- Existing studies suggest heparin is beneficial with few side effects in ulcerative colitis.
Purpose of the Study:
- To review clinical reports on heparin use in acute ulcerative colitis.
- To explore the potential mechanisms of heparin's efficacy in ulcerative colitis.
- To highlight heparin as a novel treatment option for ulcerative colitis.
Main Methods:
- Literature review of clinical case reports and studies on heparin for ulcerative colitis.
- Analysis of proposed biological mechanisms of heparin action.
- Synthesis of evidence regarding heparin's anti-inflammatory and tissue repair effects.
Main Results:
- Clinical reports consistently show positive outcomes with heparin treatment in ulcerative colitis.
- Heparin demonstrates anti-inflammatory actions and potentiates growth factors for mucosal repair.
- Observed benefits exceed simple anticoagulant effects, suggesting broader biological activity.
Conclusions:
- Heparin presents a novel therapeutic avenue for acute ulcerative colitis.
- Its anti-inflammatory and tissue-regenerative properties may explain its efficacy.
- Further research is warranted to elucidate heparin's mechanisms and optimize its use in ulcerative colitis management.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...